<section class="horizon">
    <div class="container">
        <div class="row">
            <div class="col-md-10">
                <p class="font-uppercase color-gradient section-subtitle">On the horizon</p>
                <h2 class="h3 section-title">
                    Measurable and accountable, a clear path towards
                    <i> product development distribution and increased market share.</i>
                </h2>
            </div>
        </div>
    </div>

    <section id="section_to-pin" class="grid-container section full section_to-pin">
        <div id="section_pin" class="section_pin">
            <div class="hr d-none d-md-block"></div>
            <div id="block_wrapper_1" class="block_wrapper">
                <img class="d-none d-md-block" src="img/investor/horizon-bg.png" alt="" />
                <div class="btn btn-gradient btn-md">2024</div>
                <h4 class="h5 color-gradient section-subtitle">Early 2024:</h4>
                <p class="">
                    <span>Launch</span> Metformin Gummies, Inhalable Sildenifil& Sumatriptan and
                    oral Tirzepatide through compounding pharmacies.
                </p>
            </div>
            <div id="block_wrapper_2" class="block_wrapper">
                <img class="d-none d-md-block" src="img/investor/horizon-bg.png" alt="" />

                <h4 class="h5 color-gradient section-subtitle">Mid 2024:</h4>
                <p class=""><span>Complete</span>pharmacokinetics and bioequivalence studies.</p>
            </div>
            <div id="block_wrapper_3" class="block_wrapper">
                <img class="d-none d-md-block" src="img/investor/horizon-bg.png" alt="" />

                <h4 class="h5 color-gradient section-subtitle">2H 2024:</h4>
                <p class="">
                    File for FDA bio-waiver for Metformin Gummies and begin ANDA process.
                    <span>Seek expedited approval</span> for oral Tirzepatide.
                </p>
            </div>
            <div id="block_wrapper_4" class="block_wrapper">
                <div class="btn btn-gradient btn-md">2025</div>
                <img class="d-none d-md-block" src="img/investor/horizon-bg.png" alt="" />

                <h4 class="h5 color-gradient section-subtitle">Early 2025:</h4>
                <p class="">Enroll <span>first patientin</span> Oral Tirzepatide Phase 3a.</p>
            </div>
            <div id="block_wrapper_5" class="block_wrapper">
                <img class="d-none d-md-block" src="img/investor/horizon-bg.png" alt="" />

                <h4 class="h5 color-gradient section-subtitle">Mid 2025:</h4>
                <p class="">
                    Report initial data from Phase 3a and begin preparations for
                    <span>FDA 505(b)2 approval.</span>
                </p>
            </div>
        </div>
    </section>
</section>
